Hemispherx (HEB) Shares Down 15% Today and Down 45% Over Last Two Weeks
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Join SI Premium – FREE
Shares of the volatile Hemispherx BioPharma (AMEX: HEB) are continuing lower today following yesterday's update on Ampligen and the resulting 8% drop in the stock. Today, Hemispherx has tumbled more than 15%.
Notably, over the last two weeks (since October 21), shares of Hemispherx have sunk by more than 45% from $1.80 to around $1.13 today. Unfortunately for the bulls, volume during this period has been, on average, pretty heavy.
Notably, over the last two weeks (since October 21), shares of Hemispherx have sunk by more than 45% from $1.80 to around $1.13 today. Unfortunately for the bulls, volume during this period has been, on average, pretty heavy.
You May Also Be Interested In
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
